Clinical Trial Update: A Prospective, Pre-market, Multi-center Study of Insignia Hip Stem in THA to Determine Implant Survivorship and PROMS. [NA]

View source ↗

Summary

A multi-center pre-market study of the Insignia Hip Stem in total hip arthroplasty is currently recruiting to assess implant survivorship and patient-reported o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis
• Rheumatoid Arthritis

Drugs mentioned

• Insignia Hip Stem

Snippet

Sponsor: Stryker Australia Pty Ltd. | Conditions: Arthritis (E.G., Degenerative Joint Disease (DJD), Osteoarthritis, and Rheumatoid Arthritis (RA)) | NA | Status: RECRUITING